Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound®As previously a ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

When best friends AnnaLee Canario and Dacia Benjamin started taking weight loss drugs together they thought it would be an ...

Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE programme. REDEFINE 2 is a 68-week efficacy and safety trial investigating ...

He tossed 3 1/3 scoreless innings in Saturday night’s 5-2 walk-off loss the Astros at CACTI Park of the Palm Beaches. los This would be Winans third big-league season. He made eight total ...

(The Hill) – A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound ... an injunction to stop the ...

Bank of America (NYSE:BAC) wrote in a note Thursday that, “Judge Mark Pittman ruled in favor of the U.S. Food and Drug Administration ... not compound tirzepatide, but similar legal challenges around ...

SALT LAKE CITY, March 4, 2025 /PRNewswire/ -- Shed, a telehealth clinic specializing in weight loss, is excited to announce the launch of Low-Dose Naltrexone (LDN), an innovative, therapeutic ...